Publications for Kourosh Lotfi
Co-author map based on ISI articles 2007-

Keywords

resistant resistance platelet patients p-glycoprotein nucleoside mrna lines leukemia kinase imatinib drug dgk deoxycytidine dck cyp3a cladribine cells analogues activation

Journal Articles

Ingrid Jakobsen Falk, Anna Fyrberg, Esbjörn Paul, Hareth Nahi, Monica Hermanson, Richard Rosenquist, Martin Höglund, Lars Palmqvist, Dick Stockelberg, Yuan Wei, Henrik Gréen and Kourosh Lotfi
  Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase
  American Journal of Hematology, 2013, 88(12), 1001-1006.

Anna Fyrberg, Karin Skoglund, M Wolk and Kourosh Lotfi
  A potential role of fetal hemoglobin in the development of multidrug resistance
  Biochemical and Biophysical Research Communications - BBRC, 2012, 427(3), 456-460.

Henrik Green, Ingrid Jakobsen Falk, Kourosh Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul and H Nahi
  Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
  The Pharmacogenomics Journal, 2012, 12(2), 111-118.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Green, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Ronnstrand, Thomas Walz and Jan-Ingvar Jönsson
  Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice
  British Journal of Haematology, 2011, 155(2), 198-208.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Anna Fyrberg, Curt Peterson, Bertil Kågedal and Kourosh Lotfi
  Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells
  Cancer Chemotherapy and Pharmacology, 2011, 68(3), 583-591.
 Web of Science® Times Cited: 4

Ulla Frödin, Sussanne Börjeson, Johan Lyth and Kourosh Lotfi
  A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up
  Bone Marrow Transplantation, 2011, 46(10), 1345-1352.
 Web of Science® Times Cited: 7

Anna Fyrberg and Kourosh Lotfi
  Optimization and evaluation of electroporation delivery of siRNA in the human leukemic CEM cell line
  CYTOTECHNOLOGY, 2010, 62(6), 497-507.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Andreas Eriksson, Kourosh Lotfi and Per Whiss
  Correction: Enhanced platelet adhesion in essential thrombocythemia after in vitro activation (vol 27 pg 82, 2010)
  Turkish Journal of Hematology, 2010, 27(3), 223-223.

Micha Milovanovic, Kourosh Lotfi, Tomas Lindahl, Claes Hallert and Petter Järemo
  Platelet Density Distribution in Essential Thrombocythemia
  Pathophysiology of Haemostasis and Thrombosis, 2010, 37(1), 35-42.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Henrik Green, Karin Skoglund, Franz Rommel, Rajaa A Mirghani and Kourosh Lotfi
  CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity
  EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66(4), 383-386.
   Fulltext  PDF  
 Web of Science® Times Cited: 18

Stergios Kechagias, Staffan Hägg and Kourosh Lofti
  Läkemedelsorsakad leverskada av kosttillskottet Fortodol: Manipulerat preparat försenade diagnos
  Läkartidningen, 2010, 107(4), 186-188.

Andreas C Eriksson, Kourosh Lotfi and Per A Whiss
  Enhanced platelet adhesion in essential thrombocythemia after in vitro activation
  TURKISH JOURNAL OF HEMATOLOGY, 2010, 27(2), 82-90.
 Web of Science® Times Cited: 1

Anna Zhenchuk, Koroush Lotfi, Gunnar Juliusson and Freidoun Albertioni
  Commentary: Mechanisms of anti-cancer action and pharmacology of clofarabine: in BIOCHEMICAL PHARMACOLOGY, ISSN 0006-2952, vol 78, issue 11, pp 1351-1359
  Biochemical Pharmacology, 2009, 78(11), 1351-1359.
 Web of Science® Times Cited: 36

Anna Fyrberg, Freidoun Albertioni and Kourosh Lotfi
  RNAi Depletion of Deoxycytidine and Deoxyguanosine Kinase in Human Leukemic CEM Cells
  Nucleosides, Nucleotides & Nucleic Acids, 2008, 27(6-7), 712-719.
 Web of Science® Times Cited: 1

Anna Fyrberg, Freidoun Albertioni and Kourosh Lotfi
  Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes
  Biochemical and Biophysical Research Communications - BBRC, 2007, 357(4), 847-853.
 Web of Science® Times Cited: 8

Kourosh Lotfi, Karin Karlsson, Anna Fyrberg, Gunnar Juliusson, Viggo Jonsson, Curt Peterson, Staffan Eriksson and Freidoun Albertioni
  The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
  Biochemical Pharmacology, 2006, 71(6), 882-890.
 Web of Science® Times Cited: 16

Anna Fyrberg, S Mirzaee and Kourosh Lotfi
  Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5′-nucleotidase I activity in MOLT-4 cells
  Nucleosides, Nucleotides & Nucleic Acids, 2006, 25( 9-11), 1201-1204.
 Web of Science® Times Cited: 1

Kourosh Lotfi, Curt Peterson and Gunnar Juliusson
  Letter: Monitoring oral cyclosporine therapy
  Bone Marrow Transplantation, 2005, 36, 367-367.
 Web of Science® Times Cited: 1

C Löfgren, L Hjortsberg, M Blennow, Kourosh Lotfi, C Paul, S Eriksson and F Albertioni
  Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells
  Biochemical and Biophysical Research Communications - BBRC, 2004, 320(3), 825-832.
 Web of Science® Times Cited: 7

Kourosh Lotfi, Gunnar Juliusson and Freidoun Albertioni
  Pharmacological basis for cladribine resistance
  Leukemia and Lymphoma, 2003, 44(10), 1705-1712.
 Web of Science® Times Cited: 16

Henrik Green, Kourosh Lotfi, Anna Lena Zackrisson and Curt Peterson
  Spontaneous Reversal of P-Glycoprotein Expression in Multidrug Resistant Cell Lines
  Pharmacology and Toxicology, 2003, 93(6), 297-304.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Kourosh Lotfi, Anna Lena Zackrisson and Curt Peterson
  Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance
  Cancer Letters, 2002, 178(2), 141-149.
 Web of Science® Times Cited: 32

Kourosh Lofti, Emma Månsson, Curt Peterson and Staffan Eriksson
  Low level of mitochondrical deoxyguanosine kinase is the dominant factor in acquired resistance to 9- -D-arabinofuranosylguanine cytotoxicity
  Biochemical and Biophysical Research Communications - BBRC, 2002, 293, 1489-1496.
 Web of Science® Times Cited: 16

Kourosh Lotfi, Emma Månsson, Joya Chandra, Yuyinh Wang, Dawei Xu, Eva Knaust, Tanja Spasokoukotskaja, Eva Liliemark, Staffan Eriksson and Freidoun Albertioni
  Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
  British Journal of Haematology, 2001, 113(2), 339-346.
 Web of Science® Times Cited: 28

Conference Articles

I. A. Jakobsen Falk, K. H. Z. Green, Kourosh Lotfi and Anna Fyrberg
  CORRELATION BETWEEN CYTIDINE DEAMINASE SINGLE NUCLEOTIDE POLYMORPHISMS AND DNA METHYLATION IN ACUTE MYELOGENOUS LEUKEMIA in ANNALS OF ONCOLOGY, vol 23, issue , pp 14-14
  ANNALS OF ONCOLOGY, 2012.


Johan Lyth, Sussanne Börjeson, Kourosh Lotfi and U Frodin
  Pain assessments during autologous stem cell transplantation in BONE MARROW TRANSPLANTATION, vol 46, issue , pp S450-S451
  BONE MARROW TRANSPLANTATION, 2011.


Christer Paul, Henrik Green, Ingrid Jakobsen Falk, Kourosh Lotfi, Esbjorn Paul, Monika Hermansson, Richard Rosenquist, Kerstin Jonsson-Videsater and Hareth Nahi
  Implications On Drug Resistance and Survival of ABCB1 Single Nucleotide Polymorphisms in Normal Karyotype De Novo AML in BLOOD, vol 114, issue 22, pp 1038-1039
  BLOOD, 2009.


E. Paul, Kourosh Lotfi, I. Jakobsen Falk, R. Rosenquist, C. Paul, H. Nahi and Henrik Green
  ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS IN DE NOVO AML WITH NORMAL KARYOTYPE - IMPLICATIONS ON DRUG RESISTANCE AND SURVIVAL
  in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.


Henrik Green, Karin Skoglund, Franz Rommel, Leif Bertilsson and Kourosh Lotfi
  Influence of CYP3A4 activity on imatinib response in paitents with chronic myeloid leukemia
  11th congress of the European Heamtology Association,2006, 2006.


Anna Fyrberg, Freidoun Albertioni and Kourosh Lotfi
  Evidence of cell cycle-dependent regulation of Deoxycytidine kinase and Cytosolic 5-nucleotidase-I activity
  10th European Society for the Study of Purine and Pyrimidine Metabolism in Man,2005, 2005.


Andreas Eriksson, Kourosh Lotfi and Per A Whiss
  Enhanced platelet adhesion in essential thrombocythemia assessed by a novel platelet function assay
  Congress of the European hematology association,2005, 2005.


Ph.D. Theses

Kerstin Willander
  Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers
  2014.


  Fulltext PDF

Karin Skoglund
  Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia
  2013.


  Fulltext PDF

Anna Fyrberg
  Nucleoside analoge cytotoxicity-focus on enzyme regulation, metabolism, and mechanisms of resistance
  2010.


  Fulltext PDF

Kourosh Lotfi
  Pharmacology and resistance mechanisms of nucleoside analogues and topoisomerase II interactive agents: studies on human leukemia cells with a focus on cross-resistance
  2001.


Licentiate Theses

Ulla Frödin
  Health-related quality of life during and after stem cell transplantation
  2013.


  Fulltext PDF